Article Details

Windward Bio Initiates Global Phase 2 Asthma Trial of - GlobeNewswire

Retrieved on: 2025-07-23 12:39:04

Tags for this article:

Click the tags to see associated articles and topics

Windward Bio Initiates Global Phase 2 Asthma Trial of - GlobeNewswire. View article details on hiswai:

Excerpt

WIN378 is a novel, recombinant, fully human monoclonal antibody engineered to have a significantly extended half-life and silenced effector function.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo